Requires the office of addiction services and supports to encourage, aid, and facilitate clinical research into the use of ibogaine in drug treatment

Latest action Apr 29, 2026

Requires the office of addiction services and supports to encourage, aid, and facilitate clinical research into the use of ibogaine in drug treatment for heroin, methamphetamine and cocaine addiction.

Not chosen yet

Where it stands

Out of committee and scheduled for a vote by the full chamber.

Introduced
In committee
Up for a vote
Passed one chamber
Passed
Enacted

New York State Senate

Same as A1522, the matching bill in the Assembly.

Amends the Mental Hygiene Law.

Committee

Alcoholism and Drug Abuse · New York State Assembly

Also referred to Alcoholism And Substance Use Disorders · New York State Senate.

Purpose, from the sponsor's memo

To encourage and fund clinical research examining Ibogaine as a possible pharmacotherapy that would suppress the craving for cocaine, methamphe- tamine, and heroin quickly and at a lower cost than current treatment methods.

Filed with the bill. Read it on nysenate.gov (opens in a new tab)

Recorded votes

Vote: Committee vote · Alcoholism And Substance Use Disorders
Senate Alcoholism And Substance Use DisordersApr 29, 2026Result: passed
(6) (0) (0) (1)

Cosponsors

Jake Ashby, Keith Brown and 3 more on Agora

Republican4
Democratic1

See the full list on nysenate.gov

The sponsor's argument

Why Nathalia Fernandez says this is needed

New York researchers have taken the lead in conducting research evaluat- ing Ibogaine. The Chairman of the Department of Pharmacology of Albany Medical College, Dr. Stanley Glick, reported that Ibogaine eliminated acute signs of opiate withdrawal in the animal model (Neuropharmacology 31: 5 pp. 497-500). He further reported that it also interrupted self- administration of morphine (European Journal of Pharmacology, 195:pp 341-345) as well as cocaine self-administration (Brain Research, 657: pp 14-22). Dr. Henry Sershen of the Nathan Klein Institute of Psychiatric Research in Orangeburg, NY reported that Ibogaine reduces preference for cocaine consumption (Pharmacology Biochemistry and Behavior, 46:pp 942-948). Dr. Patricia Broderick of the City University of New York MedicAl School, Department of Pharmacology, demonstrated that the effects of Ibogaine are consistent with current views regarding rational strategies for cocaine treatment. NIDA Research Monograph Series 119.

This is the sponsor's own case for the bill, quoted from their memorandum. It is not Agora's description of what the bill does.

Full history

Apr 29, 2026
Reported out of committee
REPORTED AND COMMITTED TO FINANCE
NY Senate
Jan 7, 2026
Referred to committee
REFERRED TO ALCOHOLISM AND DRUG ABUSE
NY Assembly
Jan 7, 2026
Referred to committee
REFERRED TO ALCOHOLISM AND SUBSTANCE USE DISORDERS
NY Senate
Jan 14, 2025
Referred to committee
REFERRED TO ALCOHOLISM AND SUBSTANCE USE DISORDERS
NY Senate
Jan 10, 2025
Referred to committee
REFERRED TO ALCOHOLISM AND DRUG ABUSE
NY Assembly

About this record

Summary: The summary comes from NY Open Legislation, the New York State Senate's public record. For more, see How we handle summaries.
Cosponsors: The list shows the cosponsors who are on Agora, A to Z. The official record may list more.
Party colors: Parties are shown in the same neutral colors.
Source: From NY Open Legislation, the NY Senate and Assembly, and official rosters. This record was last updated Oct 31, 2026. About our data

Read the record

Read on NY Senate (opens in a new tab) The official record on nysenate.gov.

Your position